Luigi Cataliotti, Aman U. Buzdar, Shinzaburo Noguchi, Jose Bines, Yuichi Takatsuka, Katarina Petrakova, Pierre Dube and Celia Tosello de Oliveira Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer Cancer 106
Version of Record online: 5 APR 2006 | DOI: 10.1002/cncr.21872
Preoperative anastrozole produced a numerically greater number of objective responses with respect to tumor size reduction compared with preoperative tamoxifen. The Pre-Operative “Arimidex” Compared to Tamoxifen (PROACT) study demonstrated that anastrozole is an effective and well-tolerated preoperative therapy that produces clinically beneficial tumor downstaging and reductions in tumor volume.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field